Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled heparin for treatment of adult respiratory distress syndrome in ICU
IRCT20190506043492N4Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of heparin in acute respiratory distress syndrome (ARDS), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Apr 2020; status: completed.
02
Drugs
heparin
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on IRCT20190506043492N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190506043492N4.